Giancarlo Fatobene
Overview
Explore the profile of Giancarlo Fatobene including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
159
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Rocha V, Fatobene G, Niederwieser D
Hematology Am Soc Hematol Educ Program
. 2021 Dec;
2021(1):264-274.
PMID: 34889391
Allogeneic hematopoietic cell transplantation (allo-HCT) is a highly complex, costly procedure for patients with oncologic, hematologic, genetic, and immunologic diseases. Demographics and socioeconomic status as well as donor availability and...
12.
Fatobene G, Shinohara M, Onstad L, Silgard E, Martin P, Milano F, et al.
Transplant Cell Ther
. 2021 Jul;
27(11):951.e1-951.e6.
PMID: 34332164
We have consistently noticed in our clinical practice eczematous dermatitis (EcD) without other pathologic findings of graft-versus-host disease (GVHD) in recipients of unrelated cord blood transplantation (CBT). We hypothesized that...
13.
Wolff D, Fatobene G, Rocha V, Kroger N, Flowers M
Bone Marrow Transplant
. 2021 Jul;
56(9):2079-2087.
PMID: 34218265
Chronic graft-versus-host disease (cGVHD) is one of the major causes of late mortality after allogenic hematopoietic stem cell transplantation. Moderate-to-severe cGVHD is associated with poor health-related quality of life and...
14.
Fatobene G, Volt F, Moreira F, Mariano L, Chevallier P, Furst S, et al.
Blood Adv
. 2020 Dec;
4(24):6327-6335.
PMID: 33351128
Double-unit unrelated cord blood transplantation (DUCBT) is an option in patients for whom a single unit is not sufficient to provide an adequate number of cells. As current guidelines on...
15.
Fatobene G, Souza G, Rodrigues C, Novis Y, Rocha V
Hematol Transfus Cell Ther
. 2020 Oct;
43(4):532-536.
PMID: 33055008
No abstract available.
16.
Buccheri V, Fatobene G, Santos F, Velasques R, Bellesso M, Atanazio M, et al.
Hematol Oncol
. 2020 Sep;
39(1):134-136.
PMID: 32881003
No abstract available.
17.
Fatobene G, Rocha V, Martin A, Hamadani M, Robinson S, Bashey A, et al.
J Clin Oncol
. 2020 Feb;
38(14):1518-1526.
PMID: 32031876
Purpose: To compare the outcomes of patients with Hodgkin or non-Hodgkin lymphoma undergoing nonmyeloablative haploidentical or unrelated cord blood (UCB) hematopoietic cell transplantation. Patients And Methods: We retrospectively studied 740...
18.
Solomon S, Martin A, Shah N, Fatobene G, Al Malki M, Ballen K, et al.
Blood Adv
. 2019 Oct;
3(19):2836-2844.
PMID: 31582392
In the absence of prospective studies that examine the effect of conditioning regimen intensity after T-cell-replete haploidentical transplant for acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), and myelodysplastic syndrome...
19.
Inamoto Y, White J, Ito R, Martin P, Fatobene G, Ito A, et al.
Blood Adv
. 2019 Sep;
3(18):2764-2777.
PMID: 31551243
Although differences in the incidence of chronic graft-versus-host disease (GVHD) across the races have been suggested, these have not been systematically investigated. This study compared the incidence, sites, severity, and...
20.
Hirose E, Campos de Molla V, Vescovi Goncalves M, Pereira A, Szor R, da Fonseca A, et al.
Clin Nutr ESPEN
. 2019 Aug;
33:213-219.
PMID: 31451264
Background: Malnutrition is a common finding in allogeneic hematopoietic stem cell transplantation (alloHSCT) patients, and there is some evidence that malnutrition might negatively affect the transplant outcomes. Method: We performed...